2016 American Transplant Congress » Poster Session D: Liver: Immunosuppression and Rejection

6:00pm-7:00pm

A Retrospective Analysis of Rabbit Antithymocyte Globulin Dosing, MELD, Race, and Weight on Infection and Rejection Rates in Liver Transplantation.

R. Imai, U. Wang.

6:00pm-7:00pm

Adding an Antimetabolite to a Calcineurin-Inhibitor-Based Immunosuppression Regimen Leads to Improved Native Renal Function After Liver Transplantation.

A. Karim, D. Conway, G. Leverson, J. Mezrich, L. Fernandez, A. D'Alessandro, D. Foley.

6:00pm-7:00pm

Association of Smoking Habits with Comorbidity 15 Years After Liver Transplantation.

S. Pischke,³ M. Lege,¹ L. Fischer,² U. Herden,² A. Lohse,³ B. Nashan,² M. Sterneck.¹

6:00pm-7:00pm

Deceased Non-A₂ Donor ABO-Incompatible Liver Transplantation – Promising Results with Anti-A/B Antibody Reduction Both Pre- and Post-Transplant.

U. Dahlgren,¹ G. Herlenius,¹ J. Mölne,² L. Rydberg,³ O. Samuelsson,⁴ W. Bennet.¹

6:00pm-7:00pm

Early Tacrolimus Exposure in Patients Treated De Novo with Once-Daily Tacrolimus After Liver Transplantation: Relationship with Acute Rejection and Long-Term Outcome.

M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, M. Prieto, P. Salvador, A. Matarranz, M. Suarez, J. Ortiz de Urbina.

6:00pm-7:00pm

Effect of Donor-Recipient Gender Mismatch in Liver Transplant Recipients: A Post-Hoc Analysis of the H2304 Study.

L. Fischer, P. de Simone, G. Dong, P. Lopez, P. Bernhardt, F. Saliba.

6:00pm-7:00pm

Evaluating the Influence of Liver Donor and Recipient Race on Tacrolimus Dose Requirements.

J. Knorr, J. Vidal, V. Navarro, R. Zaki.

6:00pm-7:00pm

Experience of Short-Term Preemptive Treatment for Cytomegalovirus Infection in Seropositive Patients After Liver Transplantation – Ten Years Result of a Single Institution.

T.-J. Wu, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, R.-S. Soong, C.-F. Lee, H.-S. Chou, K.-M. Chan, W.-C. Lee.

6:00pm-7:00pm

Influence of Donor and Recipient CYP3A4, CYP3A5 and ABCB1 Genotypes on Outcomes in Liver Transplants.

M. Debette-Gratien,¹ J. Woillard,² N. Picard,² M. Sebbagh,⁴ D. Sautereau,⁵ V. Loustaud-Ratti,¹ D. Samuel,³ P. Marquet.²

6:00pm-7:00pm

Pre-Transplant Risk Factors: Predicting Nonadherence and Rejection in Adult Liver Transplant Recipients.

S. Lieber,¹ J. Helcer,¹ E. Leven,¹ C. Knight,² C. Wlodarkiewicz,² A. Shenoy,¹ E. Shemesh,¹ S. Florman,³ T. Schiano,³ R. Annunziato.¹

6:00pm-7:00pm

Preoperative Cytokine Storm in High MELD Patients Accentuates Incidence of Rejection Following Liver Transplantation.

A. Mathur, E. Presbyskowski, E. Zorn, K. Rogers, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, T. Kato, J. Emond.

6:00pm-7:00pm

Sublingual Tacrolimus in Liver Transplantation: A Valid Option?

M. Moreno Gonzales,¹ L. Myhre,² T. Taner.¹